Drug intelligence / Profile preview

IY-NT-T

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

IY-NT-T is an investigational drug currently being evaluated in a Phase 1 clinical trial to assess its safety and pharmacokinetics in healthy adult volunteers. The available information indicates that the study is focused on determining how the drug behaves in the body (pharmacokinetics) and its safety profile under fed conditions. No additional details regarding its mechanism of action, therapeutic class, target indications, or molecular modality are publicly available at this time.

Brand names: Noltec
Other names: ilaprazole

Targets

ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on IY-NT-T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IY-NT-T.

Explore the full profile